Arjunadi Vati
Arjuna : Terminalia arjuna
Arjunadi Vati is a simple, single-herb Ayurvedic preparation made from Arjuna (Terminalia arjuna). Traditionally valued for its cardiac supportive and strengthening properties, it is used to support cardiovascular wellbeing, healthy circulation and physical strength.
- Product form
- Tablet / Vati
- Pack size
- 90 tablets
- Route
- Oral
Available Forms
- Vati / Tablet
Overview
Arjunadi Vati is a simple, single-herb Ayurvedic preparation made from Arjuna (Terminalia arjuna). Traditionally valued for its cardiac supportive and strengthening properties, it is used to support cardiovascular wellbeing, healthy circulation and physical strength.
Traditional Ayurvedic Perspective
In Ayurveda, Arjuna is traditionally described as Hridya, reflecting its association with heart health and cardiac strength. It is also valued for its Balya and restorative properties and is traditionally included in Ayurvedic care for Hridroga and overall cardiovascular wellbeing.
Ayurvedic Actions
- Hridya
- Traditionally valued for supporting the heart and cardiac strength.
- Balya
- Traditionally associated with strength and nourishment.
- Rasayana
- Traditionally valued for restorative and supportive care.
- Kapha-Pitta Balance
- Traditionally considered supportive of balanced Kapha and Pitta.
Traditionally Used To Support
- Heart and cardiovascular wellbeing
- Healthy cardiac function
- Healthy circulation
- Physical strength and endurance
- General weakness and fatigue
- Long-term cardiovascular support as part of an Ayurvedic care plan
Composition
Arjuna
- Botanical name
- Terminalia arjuna
- Common name
- Arjuna
- Family
- Combretaceae
- Part traditionally used
- Stem bark
Botanical Profile
Terminalia arjuna is a large deciduous tree traditionally used in Ayurveda. Its stem bark is the principal medicinal part and contains a range of naturally occurring constituents, including tannins, flavonoids, triterpenoids and other phytochemicals.
Suggested Dosage
Two tablets twice or three times daily, or as directed by an Ayurvedic physician.
If you have a diagnosed cardiovascular condition or take regular heart or blood-pressure medicines, consult our Ayurvedic physician before use.
Storage
Store in a cool, dry place away from direct sunlight and moisture.
Keep the container tightly closed after use.
Keep out of reach of children.
Ayurveda References
Charaka Samhita
Arjuna (Terminalia arjuna) is mentioned in the classical Ayurvedic literature and included among important herbal groups described by Charaka.
Reference: Charaka Samhita – Sutra Sthana 3/5, 4/43; Vimāna Sthana 8/144; Chikitsa Sthana 6/27, 6/31, 26/272.
Sushruta Samhita
Arjuna is included in classical drug groups such as Nyagrodhadi and Salasaradi Gana in Sushruta Samhita.
Reference: Sutra Sthana 14/36, 38/12; Chikitsa Sthana 1/97, 2/65; Uttara Tantra 12/11, 45/23.
Ashtanga Hridaya
Arjuna is described in the classical Dravyaguna tradition and associated with groups including Nyagrodhadi Gana.
Reference: Sutra Sthana 15/41, 29/72; Chikitsa Sthana 6/53, 11/37, 12/7–17.
Research Highlights
Terminalia arjuna and Cardiovascular Health
Scientific review
Several experimental and clinical studies have investigated Terminalia arjuna for cardiovascular applications. Research has explored its potential cardioprotective, antioxidant, lipid-modulating and vascular effects.
The available evidence is promising but researchers have also highlighted the need for larger, well-designed clinical trials and better standardisation of Arjuna preparations.
Reference
Dwivedi S, Chopra D.
Revisiting Terminalia arjuna – An Ancient Cardiovascular Drug.
Journal of Traditional and Complementary Medicine. 2014;4(4):224–231.
PMID: 25379463
DOI: 10.4103/2225-4110.139103
Arjuna and Coronary Artery Disease
A comprehensive review of Terminalia arjuna examined traditional use, preclinical research, clinical studies and safety in relation to coronary artery disease and cardiovascular health. The review describes evidence investigating anti-ischemic, antioxidant, lipid-modulating and other cardiovascular effects.
The authors also highlighted the need for further research to establish the appropriate role, standardisation and long-term safety of Arjuna preparations.
Reference
Kapoor D, Vijayvergiya R, Dhawan V.
Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation.
More products in this form
Other preparations in vati and tablets.



